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Abstract Many small peptides can be displayed on every copy
of the major coat protein in recombinant filamentous bacter-
iophages but larger peptides can only be accommodated in hybrid
virions mixed with wild-type protein subunits. A peptide insert of
12 residues capable of display at high copy number in a hybrid
virion was found to be incapable of supporting recombinant virion
assembly, a defect that could not be overcome by over-expressing
leader peptidase in the same Escherichia coli cell. In contrast,
over-expressing leader peptidase did increase the copy number of
two 9-residue peptides that were poorly incorporated into hybrid
virions. The factors that limit peptide display are varied and not
restricted to the early stages of viral assembly.
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1. Introduction
The ¢lamentous bacteriophage fd can be engineered to dis-
play small (6^8 residue) foreign peptides in the N-terminal
region of all 2700 copies of the major coat protein (pVIII)
of recombinant virions, but larger peptides can only be ac-
commodated in hybrid virions in which modi¢ed and wild-
type coat protein subunits are interspersed [1,2]. pVIII con-
tains 50 amino acid residues and is largely K-helical. It is
synthesised as a precursor, termed pro-coat, with an N-termi-
nal signal peptide of 23 amino acids. The pro-coat is inserted
into the inner membrane of the Escherichia coli cell and proc-
essed to form mature pVIII by leader peptidase [3,4], inde-
pendently of the sec translocation apparatus [5]. A good cor-
relation has been found between the e¡ect of a peptide insert
on the rate of processing of the pro-coat and the number of
copies of mature modi¢ed protein in the assembled hybrid
virion [6]. Defects in either membrane insertion or cleavage
of the pro-coat by leader peptidase could lower the processing
rate and hence the incorporation of a modi¢ed coat protein
into hybrid virions.
Foreign peptides are incorporated into the N-terminal re-
gion of pVIII without any detectable e¡ect on the structure of
the viral capsid, as judged by X-ray ¢bre di¡raction, and
model building suggests that the peptide inserts should be
able to adopt folded conformations well clear of the viral
surface [6]. The antigenic properties of displayed peptides
[7,8], together with direct structural analysis of peptide inserts
by means of NMR spectroscopy [9], are consistent with this
view. Structural constraints at the surface of the virion are
therefore unlikely to limit the size of peptide insert in pVIII.
We have modi¢ed the genome of the ¢lamentous bacterio-
phage fd to include a gene encoding L-lactamase. This enabled
us to select ampicillin-resistant E. coli cells that harbour re-
combinant virions with a 12-residue insert in every copy of
pVIII, but such virions did not form plaques and were pro-
duced in vanishingly small quantities when compared with
wild-type bacteriophage. The simultaneous over-expression
of leader peptidase from a plasmid in the E. coli host cells
did not enhance the production of recombinant virions dis-
playing the 12-residue peptide. In contrast, over-expression of
leader peptidase did increase the copy number of two 9-resi-
due peptide inserts displayed at low levels in hybrid virions,
suggesting that di¡erent factors a¡ect display of di¡erent pep-
tides at di¡erent stages in the virus assembly pathway.
2. Materials and methods
2.1. Materials
Bacteriological media were from Difco. E. coli strain TG1 recO
(K12,vlac-proAB), supE, thi, hsdv5, recO: :Tn5 Kanr/FPtraD36,
proAB, lacIq, lacZvM15) used in all experiments was the gift of
Dr. P. Oliver (Department of Genetics, University of Cambridge).
The plasmid pRD8 was a gift of Prof. Dr. A. Kuhn (Institut fuºr
Mikrobiologie, Universitaºt Hohenheim, Stuttgart). All enzymes were
from Pharmacia LKB Biotechnology, unless otherwise stated. Poly-
merase chain reactions (PCR) were performed with Pfu DNA poly-
merase (Stratagene).
2.2. Construction of phage display vectors
Recombinant DNA procedures were carried out as described else-
where [10]. All DNA sequences were con¢rmed by automated DNA
sequencing. Plasmids pfd8B and plasmid pKD encoding gene VIII
with the peptides ALWGFFPVL and PKLRGDLQVLAQ, respec-
tively, inserted between amino acids 3 and 4 of the mature pVIII
have been described previously [6]. To create the bacteriophage vector
fdAMPLAY8, new restriction sites for XmaI (a SmaI isoschizomer)
and XbaI were introduced into the intergenic region of wild-type
bacteriophage fd by site-directed mutagenesis using the oligonucleo-
tide OLfdXEXrev. (5P-CAAAAATCCTTATAAATCTAGAGAA-
TTGCCCGGGTTAGTTGTGCGTG-3P) generating bacteriophage
fdSX. The primers OLPKXb1for. (5P-CGCACTCCCGTTCTAGA-
TAATGTTTTTTGC-3P) and OLPKXb1rev. (5P-GGGATTTTGG-
TCTAGAGATTATCAAAAAGG-3P) were used to amplify a DNA
fragment consisting of the tac promoter, the gene VIII and the
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L-lactamase-encoding gene from the vector pfd8SY [11]. The PCR
product was digested with XbaI and cloned into XbaI-digested
fdSX, to generate fdPSY. This bacteriophage vector was digested
with XmaI and HindIII and the linker 5P- CCGGGCT-
ATTCTTTTG-3P, 3P-CGATAAGAAAACTCGA-5P was cloned into
it to yield bacteriophage vector fdAMP which lacks a HindIII site. A
HindIII site was created in the gene III of fdAMP by site-directed
mutagenesis using the oligonucleotide OLfdH3rev. to yield fdAMPH3
(an N15A mutation was introduced in the mature gene III protein).
The DNA fragment containing gene VIII generated by SnaBI/HindIII
digestion of pfd8SY [11] was cloned into the SnaBI/HindIII-digested
RF DNA of fdAMPH3 to yield fdAMPLAY8 (Fig. 1). The presence
of the gene encoding L-lactamase confers ampicillin resistance on
virus-infected cells.
A PCR fragment obtained by using the oligonucleotides OLfdHSN-
BIfor. (5P-GGAAACAGAATTTACGTATTTTACCCG-3P) and
OLfdHSTYIrev. (5P-GGGAGTCAAAGGCCGCCTTGGCGGGA-
TCGTT-3P) as primers and pKD [6] as the template was digested
with SnaBI/StyI and cloned into similarly digested pfd8SY [11] to
generate pfd8D. A PCR product was obtained by using pfd8D as
the template and the oligonucleotides OLfdRIfor. (5P-CGT-
TTTAGGTTGGTGAATTCGTAGTGGCAT-3P) and OLfdH3rev.
(5P-CGTTAGTAAATGAAGCTTCTGTATGAGGTT-3P) as primers.
This product was digested with SnaBI/HindIII and cloned into fdAM-
PLAY8 to create fdAMPD. Cloning the SnaBI/HindIII fragment
from the plasmid pfd8N [6] into the similarly digested RF DNA of
bacteriophage fdAMPLAY8 created the bacteriophage fdAMPN. The
plasmids pTfd8SY and pTfd8D were obtained by cloning the EcoRI/
ScaI fragments from plasmids pfd8SY and pfd8D into the plasmid
pTfd8SHU [12]. The oligonucleotides IN-1 (5P-GGCATTCT-
GGGTTTCGTGTTCACGCTG-3P) and IN-2 (5P-CAGCGTGAA-
CACGAAACCCAGAATGCC-3P) were treated with polynucleotide
kinase, annealed together and ligated into HpaI-digested pKfdH [1]
to form plasmid pKIN encoding the peptide GILGFVFTL in pVIII.
2.3. Construction of leader peptidase expression plasmid
The L-ribulokinase promoter (araB) contained in the SalI/AvaI frag-
ment from the vector pRD8 [13,14] was ¢rst cloned into the plasmid
pACYC184 (New England Biolabs) to obtain the plasmid pARA. The
SalI/SmaI fragment from pRD8 containing the leader peptidase gene
(lep) and the SalI/AvaI fragment from pARA containing the araB
promoter were then cloned into AvaI/EcoRV-digested pACYC184,
to yield the plasmid pLEP (Fig. 2).
2.4. Puri¢cation and characterisation of recombinant and hybrid virions
A single plaque of bacteriophage fd was introduced into 1.5 ml of
a 1:100 dilution in 2UTY medium of an overnight culture of E. coli
cells transformed (if appropriate) with the relevant plasmid(s). The
medium for cells expressing the pLEP plasmid also contained
200 Wg/ml L-arabinose and 50 Wg/ml chloramphenicol. The culture
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Fig. 1. (a) Schematic diagram of the genome of bacteriophage vector fdAMPLAY8 used for making recombinant bacteriophage virions;
AmpR, gene encoding ampicillin resistance; VIII, gene VIII of bacteriophage fd; III, gene III of bacteriophage fd. (b) Amino acid sequence of
the pro-coat of bacteriophage fd plus the DNA and amino acid sequences corresponding to residues 31 to +10 in wild-type fd and fdAM-
PLAY8. The cloning sites are underlined and indicated in italics.
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was grown at 37‡C until turbid and then used to inoculate 100 ml of
fresh medium. For induction, IPTG was added (¢nal concentration
10 WM) when the culture reached an A600 of 0.9^1.0. The bacterio-
phage virions were precipitated from the culture supernatant and
subjected to N-terminal sequence analysis [6,15].
3. Results
3.1. Display of long peptides in recombinant virions
Bacteriophage fdAMPLAY8 (Fig. 1) has a gene encoding
L-lactamase in the intergenic region, conferring ampicillin re-
sistance on infected cells. The wild-type gene VIII of fdAM-
PLAY8 was replaced with gene VIII from plasmid pKD [6]
creating bacteriophage fdAMPD with a 12-residue peptide D,
PKLRGDLQVLAQ, inserted between amino acids 3 and 4 in
the mature pVIII. This peptide was chosen because the cor-
responding pro-coat is known to undergo rapid membrane
insertion and processing by leader peptidase and the mature
pVIII is displayed at high levels in hybrid virions [6]. E. coli
cells transfected with fdAMPD DNA did not form the usual
plaques on a lawn but did grow as colonies on a plate made
up in 2UTY medium containing 100 Wg/ml ampicillin. The
DNA from a single colony was sequenced to con¢rm the
presence of the peptide D insert in the bacteriophage pVIII.
No virions could be isolated by the usual PEG precipitation
of a culture supernatant. After treatment of the culture super-
natant at 60‡C for 20 min to kill any remaining E. coli cells,
fresh cells were transduced to ampicillin resistance with a tu of
about 104 per ml, a value well below that of bacteriophage
fdAMPLAY8 or wild-type fd (both about 1011 per ml).
As a control, we repeated the experiment with the recombi-
nant bacteriophage fdAMPN, displaying the 6-residue insert
VIAMPS, whose pro-coat is also capable of undergoing rapid
membrane insertion and processing [6]. Unlike bacteriophage
fdAMPD, this recombinant bacteriophage generated plaques
on a lawn of E. coli cells (although smaller than the plaques
generated by bacteriophage fdAMPLAY8) with a tu of about
1011 per ml.
E. coli cells were also transformed with pTfd8D which enc-
odes pVIII containing the same peptide D insert as fdAMPD
and additionally confers tetracycline resistance. These cells
were infected with bacteriophage fdAMPD and grown in
2UTY medium containing ampicillin (100 Wg/ml) and tetracy-
cline (50 Wg/ml). As before, a tu of only 104 per ml of super-
natant was obtained, despite the additional modi¢ed pVIII
derived from the plasmid gene, indicating that the low yield
of recombinant virions was not due to a lack of modi¢ed
pVIII in the assembly process.
The plasmid pLEP (Fig. 2) carries a chloramphenicol resist-
ance marker and the gene for leader peptidase under the con-
trol of the araB promoter. E. coli cells containing the pLEP
plasmid were infected with fdAMPD bacteriophage and
grown under chloramphenicol and ampicillin selection in
2UTY medium containing 200 Wg/ml arabinose. Over-produc-
tion of leader peptidase was con¢rmed by submitting the cell
lysate to SDS-PAGE (Fig. 3). The supernatant from
fdAMPD/pLEP cultures still exhibited a tu of only 104 per
ml. Thus, over-producing leader peptidase in the infected cell
also did not increase the production of a recombinant virion
displaying peptide D in all 2700 copies of pVIII.
3.2. E¡ect of over-producing leader peptidase on peptide
display in hybrid virions
Two 9-residue cytotoxic T-cell peptide epitopes with amino
acid sequences ALWGFFPVL and GILGFVFTL were intro-
duced between residues 3 and 4 of mature pVIII, encoded by
plasmids pfd8B and pKIN, respectively. These peptides were
chosen because their copy number in hybrid virions is very
low compared with other peptide inserts [6]. E. coli cells har-
bouring pfd8B or pKIN were simultaneously co-transformed
with pLEP. Control cells were transformed only with the
plasmid pfd8B or pKIN. Hybrid bacteriophage virions were
produced either with or without induction with IPTG (¢nal
concentration of 10 WM). Cells transformed with pLEP were
simultaneously induced with 200 Wg/ml L-arabinose. Hybrid
virions were puri¢ed and subjected to SDS-PAGE but no
clear resolution of the wild-type and modi¢ed coat proteins
was achieved owing to the nature of the peptide inserts and
lack of additional charged amino acids.
N-terminal sequence analysis was used to determine the
extent of incorporation of the modi¢ed coat protein [6,15].
The percentage of modi¢ed coat protein in bacteriophage vi-
rions produced from E. coli cells not containing the pLEP
plasmid and not induced with IPTG was 5^10% for peptide
B and 1% (barely detectable) for peptide IN. Paradoxically,
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Fig. 2. Schematic diagram of the vector pLEP. The plasmid has the
p15A origin of replication and contains the leader peptidase gene
(lep) under the in£uence of the araB promoter, Para. It also carries
the chloramphenicol resistance marker, CmR.
Fig. 3. Over-expression of leader peptidase in E. coli cells. Cells
transformed with plasmids pfd8B and pLEP or pKIN and pLEP
were infected with bacteriophage fdAMPD. The 2UTY medium
contained 50 Wg/ml chloramphenicol, 200 Wg/ml arabinose and
100 Wg/ml ampicillin. The cell lysates were submitted to SDS-
PAGE. Lane 1, molecular weight markers; lane 2, pLEP; lane 3,
pKK223; lane 4, pfd8B; lane 5, pfd8B+pLEP; lane 6, pKIN;
lane 7, pKIN+pLEP.
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the percentage display of peptide B decreased to 2^5% after
induction with IPTG. These cell cultures also showed a sub-
stantial fall in A600 on induction, although after a few hours
the cells started to grow again and the absorbance recovered.
In contrast, display of peptide B in hybrid virions produced
from cells expressing pfd8B and pLEP increased to 15^20%
and this increased further, to 20^25%, when the cells were
induced with 10 WM IPTG. The cells also grew well after
the induction, unlike those without the pLEP plasmid. A sim-
ilar increase in copy number from 1 to 5% of pVIII-IN was
observed in hybrid virions prepared from cells expressing
pLEP as well as pKIN. In this case addition of IPTG did
not increase the copy number further.
4. Discussion
X-ray di¡raction analysis and model-building experiments
[6] reveal no structural impediment to the display of large
peptides (up to 5 kDa) in pVIII on the surface of a recombi-
nant ¢lamentous bacteriophage. However, we found it impos-
sible to generate a recombinant virion (fdAMPD) displaying a
12-residue peptide (the culture had a tu of only about 104 per
ml) despite the ampicillin selection made possible by the
fdAMPLAY8 vector. In contrast, bacteriophage fdAMPN
displaying a 6-residue insert achieved a tu of about 1011 per
ml, comparable with wild-type fd. Yet the pro-coats for both
recombinant virions undergo membrane insertion and proc-
essing at similar high rates in the E. coli cell [6]. Moreover, the
yield of bacteriophage fdAMPD was not increased by simul-
taneously over-expressing the modi¢ed pro-coat from the
plasmid pTfd8D or by over-expressing leader peptidase from
plasmid pLEP, in the virus-infected cell. Thus peptide inserts
in pVIII can a¡ect virion assembly by mechanisms other than
slowing down membrane insertion and processing.
Over-production of leader peptidase, however, did increase
the frequency of display of two peptides, B (ALWGFFPVL)
and IN (GILGFVFTL), in a hybrid virion. Both peptides
were initially displayed at very low frequency (5^10% and
1%, respectively) but in both cases over-expression of leader
peptidase increased the copy number of the peptides, to 20^
25% and 5%, respectively. Leader peptidase may recognise a
speci¢c conformation of the pre-protein [16,17]. The presence
of certain peptide inserts in the pro-coat may therefore gen-
erate an unfavourable secondary or tertiary structure, which
lowers the susceptibility to leader peptidase. The fall observed
in the copy number of coat proteins displaying peptide B in
hybrid virions produced after induction with IPTG in the
absence of additional leader peptidase may be due to the
accumulation of modi¢ed pro-coat in the E. coli cell inner
membrane undergoing slow processing. In contrast, the
same induction of E. coli cells expressing pLEP increased
the copy number. This would be consistent with the extra
leader peptidase helping to release the pro-coat from the
membrane for virus assembly, thereby reducing any damage
to the cell membrane.
The present results demonstrate that the barrier to display
of large peptides in pVIII on recombinant virions is not sim-
ply one of membrane insertion and processing of the modi¢ed
pro-coat but may arise also at a later stage of the assembly
process. It has previously been suggested that a proposed
membrane channel of bacteriophage pIV molecules through
which the virion emerges from the infected E. coli cell may be
of insu⁄cient diameter to allow egress of a greatly enlarged
capsid [18]. It has also been suggested [19] that the modi¢ed
pVIII molecule may not be able to interact properly with
pVII, a minor coat protein found at one end of the assembled
virion, to initiate the viral assembly process. Such impedi-
ments in the assembly pathway may make it impossible to
generate a recombinant virion in which each copy of pVIII
displays a peptide of more than about six to eight amino acid
residues. The simultaneous provision of wild-type pVIII over-
comes this limitation, perhaps by initiating the assembly proc-
ess and, if necessary, by ensuring that the resultant hybrid
virion is still capable of passing through the pIV channel.
Nonetheless, the ability to increase the copy number of
peptides displayed at low frequency in hybrid virions by
over-producing the E. coli leader peptidase signi¢cantly ex-
tends the utility of the ¢lamentous bacteriophage system for
the multiple display of foreign peptides. This could be of
importance in various applications, such as the use of the
virions in vaccine design.
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